Search
Search Results
##search.searchResults.foundPlural##
-
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1167PDF: 602HTML: 6798 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
2757PDF: 1009HTML: 411TABLE: 188FIGURES: 252 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
2005PDF: 1630HTML: 14622Untitled: 204Untitled: 175 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10594PDF: 6351HTML: 21785 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5273PDF: 2564HTML: 30196Antinori Tables 1,2,3: 347 -
EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015
1969PDF: 991HTML: 423 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1301PDF: 611HTML: 230 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1851PDF: 1050HTML: 253 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3219PDF: 1430HTML: 5845Fig1-Ag-Pil: 226Ag-Pil Fig.2: 227 -
A MULTICENTER ICET-A STUDY ON AGE AT MENARCHE AND MENSTRUAL CYCLES IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA (TDT) WHO STARTED EARLY CHELATION THERAPY WITH DIFFERENT CHELATING AGENTS. Age at menarche and menstrual cycles in patients with transfusion-dependent thalassemia.
780PDF: 497HTML: 112 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1359PDF: 815HTML: 1026Untitled: 185 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1808PDF: 809HTML: 10234Figures 1,2,3: 173 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2779PDF: 1015HTML: 360Preferred Reviewers: 204 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2141PDF: 829HTML: 926Patient’s family tree: 168 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1957PDF: 711HTML: 684Table1: patient's characteristics: 155Table 2: profile of each patient: 178 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3263PDF: 1534HTML: 421 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3237PDF: 1334HTML: 4129 -
THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS
2756PDF: 1077HTML: 1914 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1423PDF: 805HTML: 315 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4726PDF: 1554HTML: 2251Untitled: 207Untitled: 222Untitled: 230Untitled: 213Untitled: 216 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
694PDF: 529HTML: 212 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1966PDF: 748HTML: 694 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1388PDF: 873HTML: 7942Untitled: 200 -
QUALITY OF LIFE IN PATIENTS WITH THALASSEMIA MAJOR AND INTERMEDIA IN KERMAN-IRAN (I.R.)
1654PDF: 755HTML: 2338Cover Letter: 182 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1243PDF: 473HTML: 18570Figure 1: 169Figure 2: 150Figure 3: 167Figure 4: 205Figure 5: 176







